3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
9
Phase 2
8
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1
1
Status
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Periampullary Cancer
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Adenocarcinoma
1
Interventions
Gemcitabine
74
Fluorouracil
31
Oxaliplatin
21
Leucovorin
21
130-nm albumin-bound paclitaxel
17
Capecitabine
14
Irinotecan
12
Albumin-Bound Paclitaxel
10
irinotecan sucrosofate
8
Radiotherapy
6
Taxes
5
Erlotinib Hydrochloride
5
folfirinox
4
rubitecan
3
Surgical Procedures, Operative
3
Specimen Handling
3
Pancreaticojejunostomy
3
Neoadjuvant Therapy
3
Drug Therapy
3
Cisplatin
3
Chemotherapy, Adjuvant
3
ruxolitinib
2
masitinib
2
dehydroftorafur
2
Saline Solution
2
S 1 (combination)
2
Paclitaxel
2
GV1001 peptide
2
Fentanyl
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pancreatic Neoplasms
×
Pancreaticoduodenectomy
×
Clear all
NCT01419002
2015-07-29
Net-Pac
CHIR-Net
Phase 3
Terminated
5 enrolled